Skip to main content
. 2011 Jul 11;174(3):253–260. doi: 10.1093/aje/kwr193

Figure 3.

Figure 3.

Benefits of using measures from the consensus measures for Phenotypes and eXposures (PhenX) Toolkit. CVD, cardiovascular disease.

HHS Vulnerability Disclosure